Femtech company Elvie raises $80M for new product development; canine genetic company Embark snags $75M; and other digital health fundings
Summary
Additional funds came from accounts managed by BlackRock Private Equity Partners, Hiro Capital, and Westerly Winds, and from existing investors Octopus Ventures and IPGL. “This further investment, alongside the wealth of expertise our new Board members bring, place Elvie in pole position to capitalize on the $50 billion femtech opportunity – and that’s only the beginning. We won’t stop until we have fulfilled our ambition to create the go-to destination for women’s health at all life stages; providing sophisticated, accurate and personalized solutions.” Embark Veterinary, a canine genetics company, closed a Series B funding round worth $75 million. The company will put the funds towards scaling product development, increasing adoption of its platform in emergency departments and urgent care centers and growing its New York office. Additional participants include Bessemer Venture Partners, Box Group, and angel investors Henry Ward, Megan Callahan, Jonathan Bush and NBA player Klay Thompson.
Funding
Classifications
AskAI Classifications
LabelsLinked Companies
